CI
TMO icon

Clal Insurance’s Thermo Fisher Scientific TMO Stock Holding History

Clal Insurance’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12K Sell
23
-12
-34% -$5.76K ﹤0.01% 185
2026
Q1 		$17K Sell
35
-13
-27% -$7.05K ﹤0.01% 164
2025
Q4 		$28K Sell
48
-34
-41% -$19.2K ﹤0.01% 148
2025
Q3 		$40K Sell
82
-10
-11% -$4.66K ﹤0.01% 136
2025
Q2 		$37K Buy
92
+15
+19% +$6.27K ﹤0.01% 132
2025
Q1 		$38K Buy
77
+63
+450% +$34.1K ﹤0.01% 132
2024
Q4 		$7K Buy
+14
New +$7.7K ﹤0.01% 129

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Clal Insurance's TMO Position: Q2 2026 in Review

Clal Insurance reduced its Thermo Fisher Scientific (TMO) stake by 34% in Q2 2026, selling an estimated $5.76K and leaving 23 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #185.

Clal Insurance first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $40K in Q3 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Clal Insurance held 23 shares of Thermo Fisher Scientific worth $12K as of Q2 2026.
  • Clal Insurance sold 12 Thermo Fisher Scientific shares in Q2 2026, an estimated $5.76K.
  • Thermo Fisher Scientific made up ﹤0.01% of Clal Insurance's portfolio in Q2 2026, its #185 holding.
  • Clal Insurance first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • Clal Insurance's Thermo Fisher Scientific position peaked at $40K in Q3 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Clal Insurance's 13F filing for Q2 2026, filed 13 Aug 2026.